Cytokine signalling is mediated by the activation of distinct sets of structurally homologous JAK 16 and STAT signalling molecules, which control nuclear gene expression and cell fate. A 17 significant expansion in the gene regulatory repertoire controlled by JAK/STAT signalling has 18 arisen by the selective interaction of STATs with IRF transcription factors. Type I interferons 19
Introduction 29
Cytokine signalling via the JAK-STAT pathway controls the development, differentiation and regulation 30 of cells in the immune system and is frequently dysregulated in disease 1 . JAK-STAT signalling is 31 mediated by four structurally related JAK kinases (JAK1, JAK2, JAK3, TYK2) and seven STAT 32
(1, 2, 3, 4, 5a, 5b, 6) proteins 2 . A hallmark of cytokine signalling is functional redundancy and 33 extensive pleiotropy, the ability of multiple cytokines to exert overlapping biological activities 3, 4 . 34 A critical question is how a limited number of JAK and STAT molecules enable such extensive 35 redundancy and pleiotropy and how gene duplication and divergence among STATs contributes 36 to specificity in cytokine signalling. 37 JAK-mediated tyrosine phosphorylation of STATs induces dimerization and translocation to the 38 nucleus where STATs bind the gamma activated sequence (GAS), a palindromic 9-11 base pair 39 (bp) DNA element, 5'-TTCN 2-4 GAA-3' in the promoter of target genes 2 . An exception occurs 40 in the response to type I and type III IFNs: These cytokines are rapidly induced during viral 41 infection and stimulate activation of a complex termed ISGF3 (IFN-stimulated gene factor 3). 42 ISGF3 contains a STAT1/STAT2 heterodimer which interacts with IRF9, a member of the IRF 43 family of transcription factors [5] [6] [7] [8] . Mammals contain ten IRF paralogs that typically bind to the 44 consensus DNA sequence 5'-AANNGAAA-3' 9-13 . As a result of STAT and IRF complex 45 formation, ISGF3 binds to a ~12-15 bp composite IFN-stimulated response DNA element 46 (ISRE) 5'-G/ANGAAAN 2 GAAACT-3'. Thus the physical association of STATs with IRFs 47 contributes to functional specificity in cytokine signalling and enables expression of IFN-48 stimulated genes (ISGs) 6, 14 . 49 IRFs contain a conserved N-terminal DNA-binding domain and a C-terminal IRF-association 50 domain (IAD; Fig. 1a ). The IAD belongs to the SMAD/FHA domain superfamily [15] [16] [17] . IRF3 is 51 the best-understood IRF family member. Signals emanating from pattern recognition receptors 52 (PRR) activate the kinase TBK1 which phosphorylates latent IRF3 13,18-20 . This phosphorylation 53 results in remodelling of an autoinhibitory segment in the IAD of IRF3, leading to dimerization 54 and interaction with the transcriptional co-activators CBP/p300 21 . Although IRF9 contains a 55 structurally related IAD, it does not share the same activation mechanism and co-activator 56 preference with IRF3: IRF9 binds to STAT2 in both unstimulated and type I/III IFN-stimulated 57 cells [22] [23] [24] . The interaction requires the IRF9-IAD and the coiled-coil domain (CCD) of STAT2 23 , 58 a domain that is conserved among STAT paralogs (Fig. 1a ). Thus, despite conservation of the 59 IRF9-IAD and the STAT2-CCD among their respective paralogs, only STAT2 and IRF9 60 interact selectively. 61
To explore the molecular basis that enables selective IFR9-STAT2 interaction, we have 62 determined the crystal structure of the IRF9-IAD in isolation and in complex with STAT2. As 63 expected, the IRF9-IAD is closely related to IRF3. However, IRF9 lacks the structural elements 64 involved in IRF3 autoinhibition thus explaining the different activation, co-factor and 65 oligomerisation requirements. IRF9 binds through a hydrophobic patch on the convex side of the 66 IAD to the tip of the STAT2-CCD. The binding interface is conserved in IRF9 and STAT2 67 orthologs but is divergent in other IRF and STAT paralogs. Point-mutations in the conserved 68 interface disrupt STAT2-IRF9 interaction in vitro and abolish ISGF3 activity in cells. Overall, 69 our data reveal the molecular basis for selective IRF9 and STAT2 interaction. Comparative 70 structural and biochemical analyses yield insights into how gene duplication, evolutionary drift 71 and natural selection of STATs and IRFs resulted in expansion of the gene regulatory repertoire 72 in cytokine signalling. 73
74

Results
75
Biochemical basis for STAT2-IRF9 interaction 76 STAT2 contains an N-domain (ND), a CCD, a DNA-binding domain (DBD), a linker domain 77 (LD), an SH2 domain and a C-terminal transactivation domain (TAD) ( Fig. 1a ). Phosphorylation 78 on Y690 enables dimerisation of STAT2 5,25 . IRF9 contains a N-terminal DBD and a C-terminal 79 IAD connected by a flexible linker ( Fig. 1a ). Previous data show that the region spanning amino 80 acids 148-324 of STAT2 and amino acids 217-377 of IRF9 are required for complex 81 formation 8,23,26 . To further delimit the interacting regions, we co-expressed STAT2 133-738 and 82 full-length IRF9 (IRF9FL) and purified the complex to homogeneity. We found that IRF9FL co-83 purified with STAT2 133-738 (Fig. 1b, lane 1) and that a C-terminal fragment of IRF9 spanning 84 182-399 was sufficient for STAT2 binding (Fig. 1b, lane 2) . Limited proteolysis using Trypsin 85 digestion resulted in C-terminal truncation of STAT2 at position 679 as revealed by LC-MS 86 (Extended Data Fig.1a ). This shows that the region beyond the SH2 domain is flexibly attached 87 and is not required for complex formation. Co-expression of STAT2 133-679 with IRF9 182-399 88 resulted in a stable complex (Fig. 1b, lane 3) . Analysis by size exclusion chromatography 89 coupled to multi-angle laser light scattering (SEC-MALLS) showed a monodisperse complex 90 with a molecular mass of 86.8 ± 0.7 kDa, in agreement with the expected mass of a 1:1 91 heterodimer ( Fig. 1c ). Chymotryptic digestion resulted in cleavage of the 14 terminal residues of 92 IRF9, further delimiting the interacting region (Extended Data Fig.1b ). Co-expression of 93 STAT2 133-679 or of the coiled-coil segment STAT2 133-315 with IRF9 182-385 resulted in stable and 94 monodisperse heterodimeric complexes (Fig. 1b, lane 4) . We conclude that the minimal regions 95 required for complex formation comprise STAT2 133-315 and IRF9 . Considering that ISGF3 96 contains a single copy of STAT1 and STAT2 27 , we propose an overall 1:1:1 stoichiometry. 97
98
The IRF9-IAD lacks the autoinhibitory element and the PRR adapter binding site 99
We obtained crystals of the IRF9 182-385 IAD, which diffracted to 1.9Å resolution, and determined 100 the structure by molecular replacement. Our final model includes residues 197-385 of IRF9 101 (Table 1) . Like other IAD domains 15,17,28 , IRF9-IAD has a MH2 domain fold -a central β -102 sandwich core (β1-β10) flanked by a set of helices and loops (Fig. 1d) . The domain has a 103 crescent-like shape with a two-helix bundle (α2, α3) on one end, where the N-and C-termini 104 are located, and helix α1 on the other end. While the β -sandwich core of the IAD domain is 105 conserved among IRFs, the connecting secondary structures and loop regions vary: For example, 106
IRF9 lacks the C-terminal tail of IRF3, constituted by the strands β 12, β 13 and helices α1 and 107 α4, which autoinhibit IRF3 in the latent form ( Fig. 1e ). This C-terminal element of IRF3 108 undergoes a conformational change from a buried, autoinhibitory configuration to an extended 109 coil structure that leads to formation of a domain-swapped dimer upon TBK1-mediated 110 phosphorylation (Extended Data Fig. 1c ) 21, 29 . The rearranged IAD of IRF3 thereby exposes a 111 hydrophobic binding site for the coactivators CBP/p300 (Extended Data Fig. 1c ). The missing 112 autoinhibitory element of IRF9 renders the hydrophobic residues of helices α2 and α3 surface 113 exposed ( Fig. 1d-e ). To identify regions of IRF9 that are potentially involved in STAT2 binding, we compiled 126 sequence alignments of IRF9 from divergent vertebrates and mapped the amino acid 127 conservation onto the IAD structure ( Fig. 2a ). We focused on conserved residues of the convex 128 surface of the β -sandwich (IF1) and helix α2 (IF2) and on residues of helix α2 and α3 (IF3), that 129 are involved in CBP/p300 binding in IRF3. We mutated these three putative interfaces in IRF9 130 and tested binding to STAT2 using a Ni 2+ -affinity pull-down assay (Fig. 2b ). Mutations in IF1 131 reduced or completely abolished IRF9 interaction with STAT2 ( Fig. 2b) . These include IF1-A 132 (R236E, F283A), IF1-B (R236E, L274A, F283A) or IF1-C (L233A, R236E, L274A F283A). In 133 contrast, mutations in IF2 (R324E, D325K, Q331E, Q333E, P335S) or IF3 (L326A, F330A, 134 I376A) retained STAT2 binding activity ( Fig. 2b ). Thus, our data suggest that STAT2 binds to 135 the convex surface of the IRF9-IAD through residues in IF1. 136
137
To analyse the impact of these mutants on STAT2-IRF9 interaction more quantitatively, we 138 measured the equilibrium binding isotherms by isothermal titration calorimetry (ITC). 139 STAT2 133-679 bound to the IRF9-IAD exothermically, with an equilibrium dissociation constant 140 (K d ) of 10 nM ( Fig. 2c ). As expected, the IF2 and IF3 mutants retained close to wild-type 141 binding affinity (Table 2 ). The double mutant IF1-A and the triple mutant IF1-B had barely 142 detectable STAT2 binding activity while binding of the quadruple mutant IF1-C was completely 143 abolished ( Fig. 2c , Extended Data Fig. 3a,b ). Thus, our data indicates that the conserved residues 144 in IF1 synergistically contribute to STAT2 binding. Previous studies have implicated a potential 145 interaction between STAT1 and the C-terminus of IRF9 but the relevance for ISGF3 signalling 146 has remained unclear 8,23,30 . We analysed the interaction between STAT1 136-713 and the IRF9-147 IAD by ITC and found an equilibrium dissociation constant, K d , of 5 µM ( Fig. 2c , Table 2 ). The 148 interaction with STAT1 is also mediated by the IF1 interface of IRF9 as the IF1-C mutant 149 completely abolished STAT1 binding (Extended Data Fig. 3c ). The 500-fold higher binding 150 affinity for STAT2 likely explains why IRF9 constitutively interacts with STAT2 but not STAT1 151 in ISGF3 signalling 23 . 152 153
Structure of the STAT2-IRF9 complex 154
We obtained crystals of IRF9-IAD 182-385 in complex with the STAT2-CCD 133-315 , which 155 diffracted to 2.7 Å resolution, and we determined the structure by molecular replacement (Table  156 1). The production of diffraction-quality crystals required surface entropy reduction by 157 introducing mutations Q242A and K243A in an exposed surface loop of STAT2. We located a 158 single copy of the STAT2-CCD in the asymmetric unit bound to the convex side of the IRF9-159 IAD (Fig. 3a) . The STAT2-CCD contains a four helix bundle with a left-handed twist similar to 160 that of other STAT proteins including STAT1, 3 and 5 with which it superposes with a root-161 mean-square-deviation (rmsd) of between 2.7 -2.9 Å for 151 aligned Cα atoms ( Fig. 3g ). As in 162 other STATs, with the exception of STAT6, helices α1 and α2 extend beyond the core of the 163 four helix bundle of the CCD. The β -sandwich core of the IRF9-IAD binds to this extension of 164 α1 and α2 of STAT2 and buries 1040 Å 2 of surface area (Fig. 3a) . The most significant 165 contribution to the binding interface is made by contacts between α1 of STAT2 which packs 166 against a shallow binding groove on the surface of the IRF9-IAD. STAT2 is the most divergent 167 STAT family member, apparently due to frequent viral targeting which has driven STAT2 168 divergence 31 . Inspection of amino acid conservation among 21 vertebrate STAT2 orthologs 169 revealed a conserved patch on the surface of α1 (Fig. 3b ). This patch, comprising residues D167, 170 D170, V171, F174 and R175, faces directly into the STAT2-IRF9 binding interface. The lead 171 anchoring residue is F174 which buries the largest solvent-accessible surface area (142 Å 2 ) 172 upon complex formation. F174 binds into a pocket on the surface of IRF9 (Fig. 3c) . 173 Unsurprisingly, a F174D mutation completely abolished complex formation with IRF9 174 (Extended Data Fig.3d ). V171 and V178 are secondary anchoring residues and project into two 175 hydrophobic pockets on IRF9. Additional interacting residues of STAT2 include D167, D170 176 and R175 from helix α1 and Q194, and L197 from helix α2 which form hydrophobic 177 interactions, van der Waals contacts and salt bridges with conserved surface residues in IRF9 178 ( Fig. 3c ). 179 180 On IRF9, the interacting amino acids are L233, R236, S247, M248, L274, A276, N278, F283 181 and Q285. The four conserved IRF9 amino acids L233, R236, L274 and F283, that are required 182 for STAT2 binding (Fig. 2b,c preventing association of STAT2 (Extended Data Fig.3g ). Hydrophobic pockets of IRF9 that 195 accommodate the secondary anchoring residues V171 and V178 of STAT2 are also missing in 196 other IRFs (Extended Data Fig.3g ). Comparison of IRF9 in the free and STAT2-bound state 197
shows the conformational rearrangements of IRF9 upon STAT2 binding (Extended Data Fig.3h ). 198
Loop L2 is displaced to accommodate STAT2 on the shallow binding groove of IRF9. This 199 binding groove is occluded in other IRFs due to a longer L2 loop that projects into the binding 200 site (Extended Data Fig.2, Extended Data Fig.3h ). In short, despite sharing a similar overall 201 structure with other IRFs, the surface features of the IRF9-IAD have diverged to enable specific 202 recognition of STAT2. 203
204 Sequence comparison of STATs shows that F174, the lead-anchoring residue for IRF9 binding 205 of STAT2, is conserved in STAT1 and STAT3 but divergent in other paralogs (Fig. 3e ). This 206 likely explains why STAT1 can interact with IRF9 8 . The 500-fold lower binding affinity of 207 STAT1 for IRF9 ( Fig. 2c ) is due to divergence of the secondary anchoring residues V171 and 208 V178. In particular, the negatively charged amino acid residues that replace V171 in STAT1 and 209 STAT3 would clash with hydrophobic residues of IRF9. To demonstrate the importance of this 210 interaction, we introduced a V171E mutation in STAT2 and found a 250-fold increased K d 211 (from 10 nM to 2.5 µM) for IRF9 binding (Extended Data Fig. 3e ). Conversely, introduction of 212 E169V into STAT1 resulted in a more than 40-fold reduced K d (from 5 µM to 116 nM; 213 Extended Data Fig. 3a ). Together, while association between STAT2 and IRF9 is driven by F174 214 of STAT2, the secondary anchor residues and in particular V171 are critical for high binding 215
affinity and specificity of the interaction. 216 217
Effects of point mutations on ISGF3 activity 218
To further analyse the physiological relevance of the IRF9-STAT2 interface for ISGF3 function 219 in cells, we introduced mutations into FLAG-tagged IRF9 and tested their interaction with HA-220 STAT2 in HEK293 cells and the impact on ISGF3 activity using an IFIT1promoter luciferase 221 reporter (IFIT1prom-Luc) in IRF9 -/-/IRF-3 -/-MEFs. While IRF9wt was able to robustly Co-222 immunoprecipitate with STAT2 (Fig. 4a, lane 2) , the interaction was reduced to background 223 levels with the IRF9 IF1-A, IF1-B or the IF1-C mutants (Fig. 4a, lanes 3-5) . IRF9 IF1-D, a 224 variant containing the mutations L233A, L274A, F283A also did not bind STAT2 (Fig. 4a, lane  225   6 ). As the IF1 mutations were sufficient to disrupt the interaction between full-length STAT2 226 and IRF9 in vivo, we conclude that the identified binding interface is necessary and sufficient for 227 this interaction. 228
229
The luciferase reporter assay showed, as expected, IFNβ induced IFIT1prom-Luc activity in 230 cells reconstituted with FLAG-IRF9wt (Fig. 4b, Extended Data, Fig. 4a ). However, cells 231 expressing the IF1 mutants exhibited only partial (IF1-A and IF1-B) or no (IF1-C) IFIT1prom-232
Luc activity in response to IFNβ. The progressive loss of activity observed with IRF9 mutants, 233 IF1-A> IFI1-B>IFI1-C correlates with our in vitro binding studies (Fig. 2b) . Not surprisingly, 234 the IF1-D variant, also did not show IFIT1prom-Luc activity (Fig. 4b ). Overall, our results show 235 that mutations to the conserved surface patch disrupt IRF9-STAT2 interaction and abolish 236 ISGF3 function in cells. 237 238
Solution structure of STAT2-IRF9 and model of the ISGF3 complex 239
We also examined the architecture of the STAT2-IRF9 complex in solution by cross-240 linking/mass spectrometry (XL-MS) and size-exclusion chromatography in line with small-241 angle X-ray scattering (SEC-SAXS). We focused on a STAT2-IRF9 complex containing an 242 extended STAT2 133-679 construct spanning from the CCD to the SH2 domain. XL-MS showed 243 intermolecular crosslinks between K183 in STAT2-CCD and K318 or K381 of IRF9-IAD, in 244 agreement with our structure (Extended Data Fig. 4b ). The SAXS scattering curve allowed us to 245 determine the radius of gyration (R g ) of 4.37±0.02 nm while the distance distribution function 246 p(r) showed a curve characteristic of an elongated particle with a maximum diameter of 14.4±0.3 247 nm (Extended Data Fig. 4c,d and inset) . These data allowed rigid body modelling of STAT2 133-248 679 spanning from CCD to SH2 domain in complex with the IRF9-IAD (Extended Data Fig. 4b) . 249
The resulting model represented a good fit to the experimental data (Extended Data Fig. 4c ). 250 Based on this model, together with available structures of DNA-bound STAT1 and IRF dimers, 251
we propose a composite model for ISGF3, containing a 1:1:1 complex of STAT1:STAT2 and 252 IRF9 bound to ISRE DNA (Fig. 4c ). In this model, the IRF9-IAD is attached to the STAT2-253 and IRF9 is critical for the function of ISGF3 and the antiviral response 23 . Our studies show that 262 the overall architecture of these domains is similar to that of other STAT and IRF paralogs. 263
However there are several important adaptations: The IRF9-IAD is missing the regulatory 264 apparatus that is used for IRF autoinhibition in the latent form and that in the activated state 265 enables IRF dimerization and interaction with the transcriptional co-activators CBP/p300 15, 17 . In 266 addition, the PRR adaptor-binding site that enables PRR-signal-dependent activation of IRF3 is 267 absent in IRF9. IRF9 binds to the tip of the STAT2-CCD using the convex surface of the β -268 sandwich core of the IAD domain. While the same surface is available in other IRF paralogs, 269 amino acid substitutions at the key anchoring points account for the preferential STAT2 binding. 270
Together, these adaptations explain why IRF9 binds constitutively and selectively to STAT2 23 . 271
The STAT2-CCD is closely related to that of that of other STATs, with the exception of STAT6, 272 which is missing the IRF9 binding site entirely. The lead-anchoring residue of STAT2, F174, is 273 conserved in STAT1 and STAT3. Amino acid residues at this position are critical for stabilizing 274 an 'antiparallel' and apparently inactive dimer structure of STAT1 (F172) and STAT5 (I174) and 275 thus play an important role in the STAT activation and inactivation cycle 34, 35 (Fig. 3e ). The 276 secondary anchoring residues V171 and V178 of STAT2 are divergent. Due to this divergence, 277 STAT1 binds with 500-fold weaker affinity to IRF9 as compared to STAT2, contributing to 278 differential binding energetics. Previous studies have reported an interaction between STAT1 279 and IRF9 under certain experimental conditions 8 , which is likely due to this residual binding 280 affinity between STAT1 and IRF9. However other experiments could not reproduce these 281 results 23 . Nevertheless, STAT1 and IRF9 appear to interact functionally on certain promoters 282 even in the absence of STAT2 36, 37 . Overall, our data shows that IRF9 selectively and 283 constitutively interacts with STAT2, but only weakly with STAT1. 284
Together, functional divergence of the STAT and IRF paralogs is due to amino acid substitutions 285
at key anchoring points in the binding interface that enable select family members (STAT2-286 IRF9) to interact with high affinity and thereby restricting interaction between other STAT and 287 IRF paralogs. Our study thus provides evidence for how gene duplication and divergence can 288 contribute to the evolution of tightly integrated systems by slight structural variation of key 289 amino acids of primordial variants. These variations resulted in new protein-protein interactions 290 that enable a significant increase in the regulatory repertoire of the mammalian cytokine 291 response. 292 293 Methods 294
Constructs, Expression and Purification 295
Sequences encoding murine IRF9, STAT1 and STAT2 and any variants described in the text, 296
were amplified by PCR from cDNA clones, and inserted between the NcoI and HindIII sites in Initial trails of IRF9 182-385 yielded crystals with inherent pathologies like twinning, translational 326 pseudo-symmetry and high copy number. To overcome these problems, we mutated surface 327 residues to induce alternate crystal packing. An E348A mutant yielded crystals in 0.1 M HEPES 328 pH 6.8, 1.5 M Ammonium phosphate monobasic and 0.1 M Ammonium sulphate that diffracted 329 to a minimum Bragg spacing of 1.9 Å. Production of diffraction quality crystals of the STAT2-330 IRF9 complex also required mutation of surface residues Q242A and K243A of STAT2 and of 331 E347A and E348A of IRF9. Crystals of the STAT2-IRF9 complex (10 mg ml -1 ) were obtained 332 in 0.2M Potassium formate and 20% PEG3350. These were further optimised by microseeding, 333 yielding crystals that diffracted to 2.7 Å resolution. 25% glycerol was used as a cryo-protectant 334 before flash cooling in liquid nitrogen. IRF9-IAD diffraction data were collected at 100 K at an 335 X-ray wavelength of 0.966 Å at beamline ID30A-1 (MASSIF-1) of the European Synchrotron 336 Radiation Facility (ESRF, Grenoble, France) with a Pilatus 6M-F detector 38 . Diffraction data for 337 crystals of the STAT2-IRF9 complex were collected at a wavelength of 0.972 Å at the beamline 338 ID23-1 of ESRF with a Pilatus 6M-F detector. Indexing and scaling of the data was performed 339 with XDS and XSCALE 39 . The structure was solved by molecular replacement using the IRF5-340 IAD (PDB; 3DSH) structure as a search model 40 . STAT2-IRF9 data was indexed with XDS and 341 scaled using AIMLESS 41 . The structure of the IRF9-IAD and STAT1-CCD (PDB; 1BF5) were 342 used as search models for molecular replacement. Final models were produced by iterative 343 rounds of automatic and manual model building and refinement, using Coot and PHENIX 42,43 . 344
The final IRF9-IAD model contained residues 197-385 and was refined to a resolution of 1.9 Å 345 with an R work and an R free of 20.6% and 24.2%, respectively ( Table 1) HEK293 cells were transfected with FLAG-IRF9wt or mutants together with HA-STAT2 429 encoding plasmids using the calcium phosphate method. Cells were lysed by sonication in 50 430 mM Hepes pH 7.4, 150 mM NaCl, 5 mM EDTA, 10% Glycerol, 1% Triton, 10 µg/mL aprotinin, 431 10 µg/mL leupeptin, 5 mM NaF, 1 mM activated Na 3 VO 4 , 2 mM p-nitrophenyl phosphate and 432 10 mM β -glycerophosphate pH 7.5. Cell lysates (1mg) were subjected to immunoprecipitation 433 using 2 μg anti-Flag M2 antibodies (F1804, Sigma-Aldrich) for 3h at 4 °C. Elution of 434 immunocomplexes was performed by incubation on ice for 2h in lysis buffer containing 100 435 g/ml FLAG-peptide (F3290, Sigma-Aldrich). Immunocomplexes were analyzed by 436 immunoblot using the anti-FLAG M2 (F1804, Sigma-Aldrich), anti-HA (ab9110, Abcam) and 437 anti-actin (A5441, Sigma-Aldrich) antibodies as described above. 438 439 Data availability. Coordinates for the IRF9-IAD and the IRF9-STAT2 complex are available 440 from the Protein Data Bank under accession number xxx and xxx, respectively. 441 442 
